OPENBIOME FOUNDATION INC.

MICROBIOME HEALTH RESEARCH INSTITUTE INC specializes in advanced microbiome analysis and translational research to support human health outcomes, leveraging cutting-edge genomic sequencing, metagenomic profiling, and bioinformatics pipelines. The company’s core capabilities include the characterization of microbial communities in clinical and environmental samples, development of biomarker signatures for disease detection, and integration of multi-omics data to inform personalized health interventions. Their technical expertise spans 16S rRNA and shotgun metagenomics, microbial functional annotation, statistical modeling of microbiome-host interactions, and validation of microbial therapeutics. A key differentiator is their focus on translating complex microbiome data into actionable clinical insights, with an emphasis on reproducibility, data standardization, and compliance with laboratory-developed test (LDT) frameworks. Award history is not available to confirm specific agency engagements or contract performance, so no definitive patterns of federal partnership can be inferred. The company’s work is likely aligned with research-driven missions within health and science agencies, though direct relationships cannot be confirmed from the provided data. The primary NAICS code 541715, Research in the Physical, Engineering, and Life Sciences, reflects a focus on non-clinical, discovery-phase biomedical research. In practice, this means the organization conducts hypothesis-driven studies in microbial ecology, host-microbe dynamics, and diagnostic development, positioning itself within the academic and federal research ecosystem rather than commercial product delivery. The entity is structured as an 8H—indicating a small business owned and controlled by a socially and economically disadvantaged individual—and is headquartered in Woburn, Massachusetts. No government certifications are currently listed. The company operates as a specialized research firm with a narrow, science-intensive market focus, serving the broader life sciences and public health research community through technical innovation rather than large-scale service delivery.